1-3 of 3
T. Myers
Close
Sort by
Journal Articles

BMP-mediated specification of the erythroid lineage suppresses endothelial development in blood island precursors

Candace T. Myers, Paul A. Krieg
Journal: Blood
Blood (2013) 122 (24): 3929–3939.
https://doi.org/10.1182/blood-2013-03-490045
Published: 2013
Includes: Multimedia, Supplemental data
Journal Articles

Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial.

Paul G. Richardson, MD, S. Jagannath, MD, D.E. Avigan, MD, M. Alsina, R.L. Schlossman, MD, A. Mazumder, MD, N.C. Munshi, MD, I. Ghobrial, MD, D. Doss, MD, M.L. McKenney, NP, M.G. Farrell, BS, D.L. Warren, BS, L.E. Lunde, BA, B. Gourley, BA, S. Vaccaro, BS, C. Delaney, BSN, S. Pountney, BS, C.S. Mitsiades, MD, PhD, T. Hideshima, MD, PhD, C. Byrne, RN, R. Knight, MD, A. Birner, Pharm D, T. Myers, MD, E. Weller, PhD, K.C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 405.
https://doi.org/10.1182/blood.V108.11.405.405
Published: 2006
Journal Articles

A Phase 1 Trial of Lenalidomide (REVLIMID ® ) with Bortezomib (VELCADE ® ) in Relapsed and Refractory Multiple Myeloma.

Paul Richardson, R. Schlossman, N. Munshi, D. Avigan, S. Jagannath, M. Alsina, D. Doss, M. McKenney, K. Hande, M. Farrell, S. Gorelik, K. Colson, D. Warren, L. Lunde, R. Michelle, G. Cole, C. Mitsiades, T. Hideshima, T. Myers, R. Knight, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 365.
https://doi.org/10.1182/blood.V106.11.365.365
Published: 2005